COMMUNIQUÉS West-GlobeNewswire

AIT Therapeutics Schedules Fiscal Second Quarter 2019 Financial Results Conference Call and Webcast
31/10/2018
Call scheduled for Wednesday, November 14 at 4:30pm Eastern Time NEW YORK, Oct. 31, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (OTC: AITB), a clinical-stage medical device and biopharmaceutical company focused on [...]
Imagin Medical Receives Approximately $1 Million From Exercise of Warrants
31/10/2018
VANCOUVER, British Columbia and BOSTON, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Imagin Medical (CSE: IME) (OTCQB: IMEXF) (Frankfurt & Stuttgart Symbol: DPD2) (“Imagin” or the “Company”) announced today that it has [...]
MacroGenics Announces Date of Third Quarter 2018 Financial Results Conference Call
31/10/2018
Rockville, MD, Oct. 31, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX) today announced that on Wednesday, November 7, 2018, the Company will release its financial results for the quarter ended September 30, [...]
Optinose to Report Third Quarter 2018 Financial Results and Corporate Updates on November 13, 2018
31/10/2018
Conference Call and Webcast Scheduled for Tuesday, November 13 at 8:00 a.m. Eastern Time YARDLEY, Pa., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by [...]
Apricus Biosciences Provides Corporate Update and Third Quarter 2018 Financial Results
31/10/2018
Company Merger with Seelos Therapeutics, Inc. Expected to Close in Fourth Quarter 2018 Apricus Shareholders Expected to Own ~15% of Estimated $94 Million Combined Company Valuation at Closing SAN DIEGO, Oct. 31, 2018 ( [...]
The Ensign Group Reports Third Quarter 2018 Results
31/10/2018
Conference Call and Webcast Scheduled for tomorrow, November 1, 2018 at 10:00 am PT MISSION VIEJO, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group [...]
XBiotech Highlights Third Quarter Developments for 2018
31/10/2018
Company Provides Updated Overview including on its Clinical and Discovery Pipeline as well as Other Corporate Initiatives AUSTIN, Texas, Oct. 31, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT) today provided an [...]
Aeterna Zentaris to Announce Third Quarter 2018 Financial and Operating Results on November 6, 2018
31/10/2018
CHARLESTON, S.C., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX: AEZS) will announce its third quarter 2018 financial and operating results after market close on Tuesday, November 6, 2018. [...]
Melinta Therapeutics Announces Appointment of Bruce L. Downey to Board of Directors
31/10/2018
NEW HAVEN, Conn., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company discovering, developing and commercializing novel antibiotics to treat serious bacterial [...]
ChromaDex to Report Third Quarter 2018 Financial Results on Wednesday, November 7, 2018
31/10/2018
LOS ANGELES, Oct. 31, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced that it will hold a conference call on Wed., Nov. 7, 2018 at 4:30 p.m. Eastern time to discuss its financial results for the third [...]
Chembio Diagnostics Announces Proposed Public Offering of Common Stock
31/10/2018
MEDFORD, N.Y., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (NASDAQ: CEMI) (“Chembio”), a provider of point-of-care diagnostic tests for infectious diseases, announced today that it has commenced an [...]
Conformis Reports Third Quarter 2018 Financial Results and Updates Fiscal Year 2018 Guidance
31/10/2018
BILLERICA, Mass., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell [...]
OrthoPediatrics Corp. Reports Third Quarter 2018 Financial Results
31/10/2018
Third Quarter 2018 Revenue Increased 27.8% Year-over-Year to $15.8 Million Full Year 2018 Revenue Growth Guidance Increased to a Range of 25.0% to 25.5% WARSAW, Ind., Oct. 31, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics [...]
TRACON to Report Third Quarter 2018 Company Highlights and Financial Results on November 7, 2018
31/10/2018
SAN DIEGO, Oct. 31, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer [...]
Dermira to Report Third Quarter 2018 Results and Host Conference Call on Wednesday, November 7, 2018
31/10/2018
MENLO PARK, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]
Editas Medicine to Host Conference Call Discussing Third Quarter 2018 Corporate Update and Results
31/10/2018
CAMBRIDGE, Mass., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (NASDAQ:EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Wednesday, November 7, 2018, [...]
Sientra to Participate in Upcoming Investor Conferences
31/10/2018
SANTA BARBARA, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ:SIEN), a medical aesthetics company, announced today that members of management are scheduled to participate in three upcoming investor [...]
Cerecor Announces Submission of Three Orphan Drug Designation Requests for Substrate Replacement Therapies to treat Congenital Disorders of Glycosylation
31/10/2018
BALTIMORE, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Cerecor Inc. (NASDAQ: CERC), a biopharmaceutical company focused on becoming a leader in development and commercialization of treatments for rare and orphan diseases in [...]
CV Sciences, Inc. to Host Third Quarter 2018 Financial Results Conference Call on Wednesday, November 7, 2018
31/10/2018
LAS VEGAS, Oct. 31, 2018 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI), preeminent supplier and manufacturer of industry leading hemp extract brand, PlusCBD Oil™ , announced that it is scheduled to host a [...]

Pages